Work

Hyperactivated mTOR and JAK2/STAT3 pathways: Crucial molecular drivers and potential therapeutic targets of inflammatory breast cancer (IBC).

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.26_suppl.60

Authors: Eleonora Teplinsky, Amanda Valeta, Rezina Arju, Shah Giashuddin, Yasmeen Sarfraz, Melissa Alexander, Farbod Darvishian, Deborah Silvera, Paul H. Levine, Salman Hashmi, Ladan Paul, Heather J. Hoffman, Baljit Singh, Judith D. Goldberg, Tsivia Hochman, Silvia Formenti, Robert Schneider, Komal L. Jhaveri

Institutions: New York University, Brooklyn Hospital Center, NYU Langone Health, George Washington University

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4244712115

Cites:

Cited by: 1

Related to: 10